← Leaderboards
Rochelle Bagatell
Dana-Farber Cancer Inst
$1,843,838
Attributed
$3,090,666
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $629.9K · FY2006–23$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,090,666 · 2
By mechanism
R01$2,493,656 · 1
K23$597,010 · 1
Top collaborators
- Steven Dubois5 shared
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Tracy T Batchelor$27,819,477
- Daphne A. Haas-Kogan$5,585,485
- Franziska Michor$16,040,992
- Steven Dubois$3,581,513
- Matthew L Freedman$13,331,420
Others in their field
Top investigators on “Toxic Effect”
- George R Seage · Abt Associates, Inc.$224,114,540
- Peter C Adamson · National Childhood Cancer Foundation$126,756,857
- Gregory H Reaman · National Childhood Cancer Foundation$123,836,183
- Carol Nesel · Westat$116,355,411
- Mary M Horowitz · Medical College Of Wisconsin$90,165,506
- Barney Sparrow · Battelle Memorial Institute$88,494,220
Research focus
Toxic EffectFutureMalignant NeoplasmsRelapseNeuroblastomaCancer TherapyDesignInsightPeripheral Blood Mononuclear CellRefractoryAdultTumorProteinsPlayChildChildhoodBlood SpecimenTreatment ProtocolsBiologyBiological MarkersAntineoplastic AgentsBiologicalCarrier ProteinsBinding (Molecular Function)
Grant awards (10)
Tumor and host markers of clinical outcomes after MIBG therapy in neuroblastoma$347,922
R01 · FY2023 · CA
Tumor and host markers of clinical outcomes after MIBG therapy in neuroblastoma$594,506
R01 · FY2021 · CA
Tumor and host markers of clinical outcomes after MIBG therapy in neuroblastoma$310,299
R01 · FY2020 · CA
Tumor and host markers of clinical outcomes after MIBG therapy in neuroblastoma$611,015
R01 · FY2019 · CA
Tumor and host markers of clinical outcomes after MIBG therapy in neuroblastoma$629,914
R01 · FY2018 · CA
Hsp90 as a Target for the Treatment of Childhood Cancer$119,402
K23 · FY2010 · CA · contact PI
Hsp90 as a Target for the Treatment of Childhood Cancer$119,402
K23 · FY2009 · CA · contact PI
Hsp90 as a Target for the Treatment of Childhood Cancer$119,402
K23 · FY2008 · CA · contact PI
Hsp90 as a Target for the Treatment of Childhood Cancer$119,402
K23 · FY2007 · CA · contact PI
Hsp90 as a Target for the Treatment of Childhood Cancer$119,402
K23 · FY2006 · CA · contact PI